Extracellular activation of fluorinated aziridinylbenzoquinone in HT29 cells EPR studies

Cecilia R Giulivi, Enrique Cadenas

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The plasma membrane of HT29 human colon carcinoma cells was characterized by EPR spectroscopy as the site for redox activation of 3,6-difluoro-2,5-bis(aziridinyl)-1,4-benzoquinone (F-DZQ). Supplementation of HT29 cells with F-DZQ yielded an EPR signal ascribed to the semiquinone species; the hyperfine splitting constants of the 11-line spectrum were 1.4 and 1.35 G for a(N) and a(F), respectively. The intensity of the EPR signal was inhibited competitively by potassium ferricyanide, a compound which has no access to the intracellular milieu and used to evaluate transmembrane NADH-ferricyanide reductase activity. The extracellular localization of the signal was confirmed by using chromium trioxalate, a membrane-impermeant spin-broadening agent, which abolished in a concentration-dependent manner the semiquinone signal originating from the metabolism of F-DZQ by HT29 cells. The intensity of the semiquinone signal was decreased by agents which block sulfhydryl groups upon alkylation, fluorodinitrobenzene and p-chloromercuribenzoate, presumably acting on plasma membrane dehydrogenases. Other flavin dehydrogenase inhibitors, such as allopurinol, deprenyl or clorgyline, and d-arginine or N(G)-methyl-l-arginine did not affect the EPR signal. Conversely, the intensity of the semiquinone signal was increased upon supplementation of HT29 cells with glucose and insulin, which may enhance the intracellular levels of electron donors for the transplasma membrane dehydrogenase activity. The extracellular semiquinone signal was abolished by superoxide dismutase by a mechanism implying displacement of the equilibrium of the autoxidation reaction. Formation of oxygen-centered radicals during this redox activity was evaluated by EPR in conjunction with the spin trap 4-POBN. A composite signal consisting of the spin adducts of methyl, hydroxyl and superoxide radicals was observed (the former arising from hydroxyl radical attack on the quinone solvent, dimethylsulfoxide). The formation of these spin adducts was abolished by superoxide dismutase and their detection became impossible in the presence of the line broadening agent chromiun trioxalate, thus indicating their extracellular formation and localization, respectively. The occurrence of a redox site at the plasma membrane of HT29 cells for the activation of this halogenated aziridinylbenzoquinone is discussed in terms of its significance for intracellular processes and a build-up of oxyradicals in the extracellular milieu. Copyright (C) 1998 Elsevier Science Ireland Ltd.

Original languageEnglish (US)
Pages (from-to)191-204
Number of pages14
JournalChemico-Biological Interactions
Volume113
Issue number3
DOIs
StatePublished - Jun 5 1998
Externally publishedYes

Fingerprint

HT29 Cells
Paramagnetic resonance
Chemical activation
Oxidation-Reduction
Cell membranes
Oxidoreductases
Cell Membrane
Hydroxyl Radical
Superoxide Dismutase
Arginine
Clorgyline
Dinitrofluorobenzene
Chloromercuribenzoates
Selegiline
Allopurinol
Membranes
Alkylation
Chromium
Dimethyl Sulfoxide
Superoxides

Keywords

  • Aziridinylbenzoquinones
  • Cancer cells
  • Electron paramagnetic resonance
  • NADH-ferricyanide reductase
  • Oxygen radicals
  • Plasma membrane
  • Plasma membrane dehydrogenase

ASJC Scopus subject areas

  • Toxicology

Cite this

Extracellular activation of fluorinated aziridinylbenzoquinone in HT29 cells EPR studies. / Giulivi, Cecilia R; Cadenas, Enrique.

In: Chemico-Biological Interactions, Vol. 113, No. 3, 05.06.1998, p. 191-204.

Research output: Contribution to journalArticle

@article{53018c5b209146d181ad418f0b091a63,
title = "Extracellular activation of fluorinated aziridinylbenzoquinone in HT29 cells EPR studies",
abstract = "The plasma membrane of HT29 human colon carcinoma cells was characterized by EPR spectroscopy as the site for redox activation of 3,6-difluoro-2,5-bis(aziridinyl)-1,4-benzoquinone (F-DZQ). Supplementation of HT29 cells with F-DZQ yielded an EPR signal ascribed to the semiquinone species; the hyperfine splitting constants of the 11-line spectrum were 1.4 and 1.35 G for a(N) and a(F), respectively. The intensity of the EPR signal was inhibited competitively by potassium ferricyanide, a compound which has no access to the intracellular milieu and used to evaluate transmembrane NADH-ferricyanide reductase activity. The extracellular localization of the signal was confirmed by using chromium trioxalate, a membrane-impermeant spin-broadening agent, which abolished in a concentration-dependent manner the semiquinone signal originating from the metabolism of F-DZQ by HT29 cells. The intensity of the semiquinone signal was decreased by agents which block sulfhydryl groups upon alkylation, fluorodinitrobenzene and p-chloromercuribenzoate, presumably acting on plasma membrane dehydrogenases. Other flavin dehydrogenase inhibitors, such as allopurinol, deprenyl or clorgyline, and d-arginine or N(G)-methyl-l-arginine did not affect the EPR signal. Conversely, the intensity of the semiquinone signal was increased upon supplementation of HT29 cells with glucose and insulin, which may enhance the intracellular levels of electron donors for the transplasma membrane dehydrogenase activity. The extracellular semiquinone signal was abolished by superoxide dismutase by a mechanism implying displacement of the equilibrium of the autoxidation reaction. Formation of oxygen-centered radicals during this redox activity was evaluated by EPR in conjunction with the spin trap 4-POBN. A composite signal consisting of the spin adducts of methyl, hydroxyl and superoxide radicals was observed (the former arising from hydroxyl radical attack on the quinone solvent, dimethylsulfoxide). The formation of these spin adducts was abolished by superoxide dismutase and their detection became impossible in the presence of the line broadening agent chromiun trioxalate, thus indicating their extracellular formation and localization, respectively. The occurrence of a redox site at the plasma membrane of HT29 cells for the activation of this halogenated aziridinylbenzoquinone is discussed in terms of its significance for intracellular processes and a build-up of oxyradicals in the extracellular milieu. Copyright (C) 1998 Elsevier Science Ireland Ltd.",
keywords = "Aziridinylbenzoquinones, Cancer cells, Electron paramagnetic resonance, NADH-ferricyanide reductase, Oxygen radicals, Plasma membrane, Plasma membrane dehydrogenase",
author = "Giulivi, {Cecilia R} and Enrique Cadenas",
year = "1998",
month = "6",
day = "5",
doi = "10.1016/S0009-2797(98)00028-3",
language = "English (US)",
volume = "113",
pages = "191--204",
journal = "Chemico-Biological Interactions",
issn = "0009-2797",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Extracellular activation of fluorinated aziridinylbenzoquinone in HT29 cells EPR studies

AU - Giulivi, Cecilia R

AU - Cadenas, Enrique

PY - 1998/6/5

Y1 - 1998/6/5

N2 - The plasma membrane of HT29 human colon carcinoma cells was characterized by EPR spectroscopy as the site for redox activation of 3,6-difluoro-2,5-bis(aziridinyl)-1,4-benzoquinone (F-DZQ). Supplementation of HT29 cells with F-DZQ yielded an EPR signal ascribed to the semiquinone species; the hyperfine splitting constants of the 11-line spectrum were 1.4 and 1.35 G for a(N) and a(F), respectively. The intensity of the EPR signal was inhibited competitively by potassium ferricyanide, a compound which has no access to the intracellular milieu and used to evaluate transmembrane NADH-ferricyanide reductase activity. The extracellular localization of the signal was confirmed by using chromium trioxalate, a membrane-impermeant spin-broadening agent, which abolished in a concentration-dependent manner the semiquinone signal originating from the metabolism of F-DZQ by HT29 cells. The intensity of the semiquinone signal was decreased by agents which block sulfhydryl groups upon alkylation, fluorodinitrobenzene and p-chloromercuribenzoate, presumably acting on plasma membrane dehydrogenases. Other flavin dehydrogenase inhibitors, such as allopurinol, deprenyl or clorgyline, and d-arginine or N(G)-methyl-l-arginine did not affect the EPR signal. Conversely, the intensity of the semiquinone signal was increased upon supplementation of HT29 cells with glucose and insulin, which may enhance the intracellular levels of electron donors for the transplasma membrane dehydrogenase activity. The extracellular semiquinone signal was abolished by superoxide dismutase by a mechanism implying displacement of the equilibrium of the autoxidation reaction. Formation of oxygen-centered radicals during this redox activity was evaluated by EPR in conjunction with the spin trap 4-POBN. A composite signal consisting of the spin adducts of methyl, hydroxyl and superoxide radicals was observed (the former arising from hydroxyl radical attack on the quinone solvent, dimethylsulfoxide). The formation of these spin adducts was abolished by superoxide dismutase and their detection became impossible in the presence of the line broadening agent chromiun trioxalate, thus indicating their extracellular formation and localization, respectively. The occurrence of a redox site at the plasma membrane of HT29 cells for the activation of this halogenated aziridinylbenzoquinone is discussed in terms of its significance for intracellular processes and a build-up of oxyradicals in the extracellular milieu. Copyright (C) 1998 Elsevier Science Ireland Ltd.

AB - The plasma membrane of HT29 human colon carcinoma cells was characterized by EPR spectroscopy as the site for redox activation of 3,6-difluoro-2,5-bis(aziridinyl)-1,4-benzoquinone (F-DZQ). Supplementation of HT29 cells with F-DZQ yielded an EPR signal ascribed to the semiquinone species; the hyperfine splitting constants of the 11-line spectrum were 1.4 and 1.35 G for a(N) and a(F), respectively. The intensity of the EPR signal was inhibited competitively by potassium ferricyanide, a compound which has no access to the intracellular milieu and used to evaluate transmembrane NADH-ferricyanide reductase activity. The extracellular localization of the signal was confirmed by using chromium trioxalate, a membrane-impermeant spin-broadening agent, which abolished in a concentration-dependent manner the semiquinone signal originating from the metabolism of F-DZQ by HT29 cells. The intensity of the semiquinone signal was decreased by agents which block sulfhydryl groups upon alkylation, fluorodinitrobenzene and p-chloromercuribenzoate, presumably acting on plasma membrane dehydrogenases. Other flavin dehydrogenase inhibitors, such as allopurinol, deprenyl or clorgyline, and d-arginine or N(G)-methyl-l-arginine did not affect the EPR signal. Conversely, the intensity of the semiquinone signal was increased upon supplementation of HT29 cells with glucose and insulin, which may enhance the intracellular levels of electron donors for the transplasma membrane dehydrogenase activity. The extracellular semiquinone signal was abolished by superoxide dismutase by a mechanism implying displacement of the equilibrium of the autoxidation reaction. Formation of oxygen-centered radicals during this redox activity was evaluated by EPR in conjunction with the spin trap 4-POBN. A composite signal consisting of the spin adducts of methyl, hydroxyl and superoxide radicals was observed (the former arising from hydroxyl radical attack on the quinone solvent, dimethylsulfoxide). The formation of these spin adducts was abolished by superoxide dismutase and their detection became impossible in the presence of the line broadening agent chromiun trioxalate, thus indicating their extracellular formation and localization, respectively. The occurrence of a redox site at the plasma membrane of HT29 cells for the activation of this halogenated aziridinylbenzoquinone is discussed in terms of its significance for intracellular processes and a build-up of oxyradicals in the extracellular milieu. Copyright (C) 1998 Elsevier Science Ireland Ltd.

KW - Aziridinylbenzoquinones

KW - Cancer cells

KW - Electron paramagnetic resonance

KW - NADH-ferricyanide reductase

KW - Oxygen radicals

KW - Plasma membrane

KW - Plasma membrane dehydrogenase

UR - http://www.scopus.com/inward/record.url?scp=0031801413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031801413&partnerID=8YFLogxK

U2 - 10.1016/S0009-2797(98)00028-3

DO - 10.1016/S0009-2797(98)00028-3

M3 - Article

C2 - 9717518

AN - SCOPUS:0031801413

VL - 113

SP - 191

EP - 204

JO - Chemico-Biological Interactions

JF - Chemico-Biological Interactions

SN - 0009-2797

IS - 3

ER -